78 related articles for article (PubMed ID: 23270420)
1. Genetic association between APOE*4 and neuropsychiatric symptoms in patients with probable Alzheimer's disease is dependent on the psychosis phenotype.
Christie D; Shofer J; Millard SP; Li E; Demichele-Sweet MA; Weamer EA; Kamboh MI; Lopez OL; Sweet RA; Tsuang D
Behav Brain Funct; 2012 Dec; 8():62. PubMed ID: 23270420
[TBL] [Abstract][Full Text] [Related]
2. Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease.
Qian W; Fischer CE; Schweizer TA; Munoz DG
Curr Alzheimer Res; 2018; 15(2):187-194. PubMed ID: 28847281
[TBL] [Abstract][Full Text] [Related]
3. Neuropsychiatric Symptoms and Trajectories of Dependence and Cognition in a Sample of Community-dwelling Older Adults with Dementia.
Kociolek AJ; Fernandez KK; Hernandez M; Jin Z; Cosentino S; Zhu CW; Gu Y; Devanand DP; Stern Y
Curr Alzheimer Res; 2023; 20(6):409-419. PubMed ID: 37694796
[TBL] [Abstract][Full Text] [Related]
4. Chain Mediation Analysis of the Effects of Nutrition and Cognition on the Association of Apolipoprotein E ɛ4 with Neuropsychiatric Symptoms in Alzheimer's Disease.
Jiang J; Hong Y; Li W; Wang A; Jiang S; Jiang T; Wang Y; Wang L; Yang S; Ren Q; Zou X; Xu J
J Alzheimers Dis; 2023; 96(2):669-681. PubMed ID: 37840496
[TBL] [Abstract][Full Text] [Related]
5. Evidence that environmental and genetic risks for psychotic disorder may operate by impacting on connections between core symptoms of perceptual alteration and delusional ideation.
Smeets F; Lataster T; Viechtbauer W; Delespaul P;
Schizophr Bull; 2015 May; 41(3):687-97. PubMed ID: 25217481
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide association study of Alzheimer's disease with psychotic symptoms.
Hollingworth P; Sweet R; Sims R; Harold D; Russo G; Abraham R; Stretton A; Jones N; Gerrish A; Chapman J; Ivanov D; Moskvina V; Lovestone S; Priotsi P; Lupton M; Brayne C; Gill M; Lawlor B; Lynch A; Craig D; McGuinness B; Johnston J; Holmes C; Livingston G; Bass NJ; Gurling H; McQuillin A; ; ; Holmans P; Jones L; Devlin B; Klei L; Barmada MM; Demirci FY; DeKosky ST; Lopez OL; Passmore P; Owen MJ; O'Donovan MC; Mayeux R; Kamboh MI; Williams J
Mol Psychiatry; 2012 Dec; 17(12):1316-27. PubMed ID: 22005930
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease.
DeMichele-Sweet MAA; Klei L; Creese B; Harwood JC; Weamer EA; McClain L; Sims R; Hernandez I; Moreno-Grau S; Tárraga L; Boada M; Alarcón-Martín E; Valero S; ; Liu Y; Hooli B; Aarsland D; Selbaek G; Bergh S; Rongve A; Saltvedt I; Skjellegrind HK; Engdahl B; Stordal E; Andreassen OA; Djurovic S; Athanasiu L; Seripa D; Borroni B; Albani D; Forloni G; Mecocci P; Serretti A; De Ronchi D; Politis A; Williams J; Mayeux R; Foroud T; Ruiz A; Ballard C; Holmans P; Lopez OL; Kamboh MI; Devlin B; Sweet RA
Mol Psychiatry; 2021 Oct; 26(10):5797-5811. PubMed ID: 34112972
[TBL] [Abstract][Full Text] [Related]
8. Examining the association between genetic liability for schizophrenia and psychotic symptoms in Alzheimer's disease.
Creese B; Vassos E; Bergh S; Athanasiu L; Johar I; Rongve A; Medbøen IT; Vasconcelos Da Silva M; Aakhus E; Andersen F; Bettella F; Braekhus A; Djurovic S; Paroni G; Proitsi P; Saltvedt I; Seripa D; Stordal E; Fladby T; Aarsland D; Andreassen OA; Ballard C; Selbaek G;
Transl Psychiatry; 2019 Oct; 9(1):273. PubMed ID: 31641104
[TBL] [Abstract][Full Text] [Related]
9. Genetic risk for schizophrenia and psychosis in Alzheimer disease.
DeMichele-Sweet MAA; Weamer EA; Klei L; Vrana DT; Hollingshead DJ; Seltman HJ; Sims R; Foroud T; Hernandez I; Moreno-Grau S; Tárraga L; Boada M; Ruiz A; Williams J; Mayeux R; Lopez OL; Sibille EL; Kamboh MI; Devlin B; Sweet RA
Mol Psychiatry; 2018 Apr; 23(4):963-972. PubMed ID: 28461698
[TBL] [Abstract][Full Text] [Related]
10. Neuropsychiatric symptoms in Alzheimer's disease: past progress and anticipation of the future.
Geda YE; Schneider LS; Gitlin LN; Miller DS; Smith GS; Bell J; Evans J; Lee M; Porsteinsson A; Lanctôt KL; Rosenberg PB; Sultzer DL; Francis PT; Brodaty H; Padala PP; Onyike CU; Ortiz LA; Ancoli-Israel S; Bliwise DL; Martin JL; Vitiello MV; Yaffe K; Zee PC; Herrmann N; Sweet RA; Ballard C; Khin NA; Alfaro C; Murray PS; Schultz S; Lyketsos CG;
Alzheimers Dement; 2013 Sep; 9(5):602-8. PubMed ID: 23562430
[TBL] [Abstract][Full Text] [Related]
11. Presenilin Gene Mutation-associated Psychosis: Phenotypic Characteristics and Clinical Implications.
Colijn MA; Ismail Z
Alzheimer Dis Assoc Disord; 2024 Jan-Mar 01; 38(1):101-106. PubMed ID: 38227890
[TBL] [Abstract][Full Text] [Related]
12. Genetics of psychosis of Alzheimer disease.
Shah C; DeMichele-Sweet MA; Sweet RA
Am J Med Genet B Neuropsychiatr Genet; 2017 Jan; 174(1):27-35. PubMed ID: 26756273
[TBL] [Abstract][Full Text] [Related]
13. Clinical and neurocognitive aspects of hallucinations in Alzheimer's disease.
El Haj M; Roche J; Jardri R; Kapogiannis D; Gallouj K; Antoine P
Neurosci Biobehav Rev; 2017 Dec; 83():713-720. PubMed ID: 28235545
[TBL] [Abstract][Full Text] [Related]
14. APOE Gene Associated with Dementia-Related Traits, Depression, and Anxiety in the Hispanic Population.
Xu C; Padilla V; Lozano S; Gamez D; Su BB; Wang X; Maestre G; Wang K
Genes (Basel); 2023 Jul; 14(7):. PubMed ID: 37510309
[TBL] [Abstract][Full Text] [Related]
15. Fine particulate air pollution and neuropathology markers of Alzheimer's disease in donors with and without APOE ε4 alleles - results from an autopsy cohort.
Christensen GM; Li Z; Liang D; Ebelt S; Gearing M; Levey AI; Lah JJ; Wingo AP; Wingo TS; Huels A
medRxiv; 2023 Apr; ():. PubMed ID: 37066193
[TBL] [Abstract][Full Text] [Related]
16. Age of Alzheimer's disease diagnosis in people with Down syndrome and associated factors: Results from the Horizon 21 European Down syndrome consortium.
Larsen FK; Baksh RA; McGlinchey E; Langballe EM; Benejam B; Beresford-Webb J; McCarron M; Coppus A; Falquero S; Fortea J; Levin J; Loosli SV; Mark R; Rebillat AS; Zaman S; Strydom A
Alzheimers Dement; 2024 May; 20(5):3270-3280. PubMed ID: 38506627
[TBL] [Abstract][Full Text] [Related]
17. Assessment and familial aggregation of psychosis in Alzheimer's disease from the National Institute on Aging Late Onset Alzheimer's Disease Family Study.
Sweet RA; Bennett DA; Graff-Radford NR; Mayeux R;
Brain; 2010 Apr; 133(Pt 4):1155-62. PubMed ID: 20147454
[TBL] [Abstract][Full Text] [Related]
18. Principles and management of neuropsychiatric symptoms in Alzheimer's dementia.
Nowrangi MA; Lyketsos CG; Rosenberg PB
Alzheimers Res Ther; 2015 Jan; 7(1):12. PubMed ID: 27391771
[TBL] [Abstract][Full Text] [Related]
19. Neuropsychiatric signs and symptoms of Alzheimer's disease: New treatment paradigms.
Lanctôt KL; Amatniek J; Ancoli-Israel S; Arnold SE; Ballard C; Cohen-Mansfield J; Ismail Z; Lyketsos C; Miller DS; Musiek E; Osorio RS; Rosenberg PB; Satlin A; Steffens D; Tariot P; Bain LJ; Carrillo MC; Hendrix JA; Jurgens H; Boot B
Alzheimers Dement (N Y); 2017 Sep; 3(3):440-449. PubMed ID: 29067350
[TBL] [Abstract][Full Text] [Related]
20. Network Systems Pharmacology-Based Mechanism Study on the Beneficial Effects of Vitamin D against Psychosis in Alzheimer's Disease.
Fan P; Qi X; Sweet RA; Wang L
Sci Rep; 2020 Apr; 10(1):6136. PubMed ID: 32273551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
